HR 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
Department of Defense appropriations for Medical Countermeasures
NDAA - provisions related to biological and chemical defense
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing / opioid prescribing
Duration: September 1, 2009
to
December 31, 2018
General Issues: Homeland Security , Budget/Appropriations , Defense , Health Issues , Disaster Planning/Emergencies
Spending: about $1,060,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: U.S. Senate, House of Representatives, Homeland Security - Dept of (DHS), Health & Human Services - Dept of (HHS), House of Representatives, Senate, Homeland Security, Dept of (DHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2018
THE ADVOCACY GROUP terminated an engagement in which they represented Emergent BioSolutions on March 4, 2019.
Original Filing: 301021041.xml
Lobbying Issues
HR 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
Department of Defense appropriations for Medical Countermeasures
Agencies Lobbied
U.S. Senate
Lobbying Issues
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing / opioid prescribing
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006554.xml
Lobbying Issues
HR 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
Department of Defense appropriations for Medical Countermeasures
Agencies Lobbied
U.S. Senate
Lobbying Issues
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing / opioid prescribing
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 22, 2018.
Original Filing: 300996523.xml
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
Lobbying Issues
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 20, 2018.
Original Filing: 300974220.xml
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
Lobbying Issues
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on April 20, 2018.
Original Filing: 300953126.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
4th Quarter, 2017
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on March 9, 2018.
Original Filing: 300941194.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
3rd Quarter, 2017
THE ADVOCACY GROUP amended a lobbying report for representation of Emergent BioSolutions in Q32017 on Oct. 20, 2017.
Original Filing: 300912780.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
3rd Quarter, 2017
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on Oct. 19, 2017.
Original Filing: 300909301.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act.
NDAA - provisions related to biological and chemical defense.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
2nd Quarter, 2017
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on July 20, 2017.
Original Filing: 300893681.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling medical countermeasures.
Provisions related to development, acquisition and stockpiling medical countermeasures.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling medical countermeasures.
Provisions related to development, acquisition and stockpiling medical countermeasures.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
1st Quarter, 2017
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on April 20, 2017.
Original Filing: 300876274.xml
Lobbying Issues
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
4th Quarter, 2016
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $20,000. The report was filed on Jan. 23, 2017.
Original Filing: 300856034.xml
Lobbying Issues
Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
S. 9267 - National Biodefense Strategy
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S. 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015
S. 2055 - Medical Countermeasure Innovation Act of 2015
H.R. 34 - 21st Century Cures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
S. 9267 - National Biodefense Strategy
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S. 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015
S. 2055 - Medical Countermeasure Innovation Act of 2015
H.R. 34 - 21st Century Cures
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
3rd Quarter, 2016
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300837029.xml
Lobbying Issues
Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination.
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination.
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
2nd Quarter, 2016
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 20, 2016.
Original Filing: 300818052.xml
Lobbying Issues
Draft-Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Draft-Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
1st Quarter, 2016
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 20, 2016.
Original Filing: 300800981.xml
Lobbying Issues
Draft-Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination.
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Draft-Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness.
Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination.
H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015.
S 2055 - Medical Countermeasure Innovation Act of 2015.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
4th Quarter, 2015
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 20, 2016.
Original Filing: 300780020.xml
Lobbying Issues
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 and S 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R 1735 and S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
3rd Quarter, 2015
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 20, 2015.
Original Filing: 300760391.xml
Lobbying Issues
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R. 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
2nd Quarter, 2015
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 20, 2015.
Original Filing: 300742857.xml
Lobbying Issues
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 & S. 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Lobbying Issues
raft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
H.R. 2685 & S. 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 20, 2015.
Original Filing: 300721790.xml
Lobbying Issues
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft - Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness
HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
Draft - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies/Appropriations
4th Quarter, 2014
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 20, 2015.
Original Filing: 300703300.xml
Lobbying Issues
HR 83 Consolidated and Further Continuing Appropriations Act, 2015 - Department of Labor, Health and Human Services , Education and related Agencies, Defense and Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
HR 3979 - National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies/Appropriations
3rd Quarter, 2014
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 17, 2014.
Original Filing: 300680106.xml
Lobbying Issues
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4870 and Draft senate bill - Department of Defense Appropriations Act, 2015 -provisions related to chemical decontamination.
Draft - Departments of LHHS Appropriation bills, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4435 and S 2410 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
HJ Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Appropriations
Lobbying Issues
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4870 and Draft senate bill - Department of Defense Appropriations Act, 2015 -provisions related to chemical decontamination.
Draft - Departments of LHHS Appropriation bills, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4435 and S 2410 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
HR Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4870 and Draft senate bill - Department of Defense Appropriations Act, 2015 - provisions related to chemical decontamination.
Draft - Departments of LHHS Appropriation bills, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4435 and S 2410 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
HJ Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 21, 2014.
Original Filing: 300666140.xml
Lobbying Issues
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4870 and Draft senate bill - Department of Defense Appropriations Act, 2015 -provisions related to chemical decontamination.
Draft - Departments of LHHS Appropriation bills, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4435 and S 2410 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
1st Quarter, 2014
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 17, 2014.
Original Filing: 300639740.xml
Lobbying Issues
HR 4007 - Chemical Facility Anti-Terrorism Standards Program Authorization and Accountability Act of 2014.
HR 4034 - WMD Prevention and Preparedness Act of 2014 -To enhance homeland security by improving efforts to prevent, protect against, respond to, and recover from an attack with a weapon of mass destruction, and for other purposes.
HR 3547 - Consolidated Appropriations Act, 2014, Department of Homeland Security Appropriations Act, 2014 and Department of Labor, Health and Human Services , Education and Related Agencies Appropriations Act 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft Consolidated Appropriations Act, 2015, Department of Homeland Security Appropriations Act, 2014 and Department of Labor, Health and Human Services , Education and Related Agencies Appropriations Act 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
4th Quarter, 2013
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 23, 2014.
Original Filing: 300628643.xml
Lobbying Issues
Dept. Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Dept. Labor HHS - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HJ Res 59 - Continuing Appropriations Resolution - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
Lobbying Issues
HR 4310, The National Defense Authorization Act, language relating to chemical decontamination.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2013
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 21, 2013.
Original Filing: 300601882.xml
Lobbying Issues
Dept. Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Dept. Labor HHS - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HJ Res 59 - Continuing Appropriations Resolution - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
2nd Quarter, 2013
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 22, 2013.
Original Filing: 300581689.xml
Lobbying Issues
HR 2217 and draft Senate bill-Department of Homeland Security Appropriations Act, 2014-provisions related to development, acquistion and stockpiling of biodefense vaccines.
S 1284 -2014 Departments of Labor, Health and Human Serivices, Education and Related Agencies appropriations bill-same issues as previously stated.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies/Appropriations
1st Quarter, 2013
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 22, 2013.
Original Filing: 300559571.xml
Lobbying Issues
Draft Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2014 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
HR 933, Consolidated and Further Continuing Appropriations Act 2013, Part D- Department of Homeland Security Appropriations, 2013, and Titles I and V of Division F- Labor and Health and Human Services, Education and Related Agencies Appropriations, provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 307 and S 42 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies
4th Quarter, 2012
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 22, 2013.
Original Filing: 300539154.xml
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies
3rd Quarter, 2012
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 22, 2012.
Original Filing: 300518044.xml
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies
2nd Quarter, 2012
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 20, 2012.
Original Filing: 300496696.xml
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Emergencies
1st Quarter, 2012
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 19, 2012.
Original Filing: 300465768.xml
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
Type of Issue
Homeland Security/Appropriations
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Department of Homeland Security Appropriations and Department of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines;
H.R. 2356 WMD Prevention and preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;
H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2012 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs;
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. Senate
4th Quarter, 2011
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 19, 2012.
Original Filing: 300442986.xml
Lobbying Issues
HR 2055, Division F, Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 WMD Prevention and Preparedness Act 0f 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Lobbying Issues
HR 2055, Division F, Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017 Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
HR 2055, Division F, Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
House of Representatives
3rd Quarter, 2011
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 14, 2011.
Original Filing: 300414031.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 WMD Prevention and Preparedness Act 0f 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017 Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
House of Representatives
2nd Quarter, 2011
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 20, 2011.
Original Filing: 300401852.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 WMD Prevention and Preparedness Act 0f 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017 Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356 - WMD Prevention and Preparedness Act of 2011- all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
House of Representatives
1st Quarter, 2011
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 20, 2011.
Original Filing: 300375439.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines
Agencies Lobbied
House of Representatives
Type of Issue
Homeland Security/Emergencies
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
House of Representatives
4th Quarter, 2010
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 19, 2010.
Original Filing: 300350860.xml
Lobbying Issues
Issues related to homeland security.
S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.
PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines.S 3140, Biosecurity and Vaccine Development Improvement Act.
Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
HR 5498, WMD Prevention & Preparedness Act of 2010.
Agencies Lobbied
House of Representatives
3rd Quarter, 2010
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Oct. 19, 2010.
Original Filing: 300319658.xml
Lobbying Issues
Issues related to homeland security.
S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.
PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines.S 3140, Biosecurity and Vaccine Development Improvement Act.
Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
HR 5498, WMD Prevention & Preparedness Act of 2010.
Agencies Lobbied
House of Representatives
2nd Quarter, 2010
In Q2, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on July 16, 2010.
Original Filing: 300289023.xml
Lobbying Issues
Issues related to homeland security.
S 1649 WMD Prevention and Preparedness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.
PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield related to stockpiling of biodefense vaccines.S 3140, Biosecurity and Vaccine Development Improvement Act.
Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
HR 5498, WMD Prevention & Preparedness Act of 2010.
Agencies Lobbied
House of Representatives
1st Quarter, 2010
In Q1, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on April 20, 2010.
Original Filing: 300271408.xml
Lobbying Issues
Issues related to homeland security.
S 1649 WMD Prevention and Prepardeness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.
PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShied related to stockpiling of biodefense vaccines.S 3140, Biosecurity and Vaccine Development Improvement Act.
Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
Agencies Lobbied
House of Representatives
4th Quarter, 2009
In Q4, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $30,000. The report was filed on Jan. 20, 2010.
Original Filing: 300240608.xml
Lobbying Issues
Issues related to homeland security.
S 1649 WMD Prevention and Prepardeness Act of 2009 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.
PL 115-5 American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding Implementation of Biomedical Advanced Research & Development Authority (BARDA) & Project BioShied related to stockpiling of biodefense vaccines.Use of state and local homeland security and bioterrorism preparedness grant funding for anthrax vaccines for first responders, on a voluntary basis.
Agencies Lobbied
House of Representatives
3rd Quarter, 2009
In Q3, THE ADVOCACY GROUP lobbied for Emergent BioSolutions , earning $10,000. The report was filed on Oct. 16, 2009.
Original Filing: 300207001.xml
Lobbying Issues
Issues related to homeland security.
S 1649 Weapons of Mass Destruction Prevention and Preparedness Act of 2009.
Agencies Lobbied
House of Representatives
Lobbying Issues
Issues related to healthcare.
Agencies Lobbied
House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...